How Good Referral Pathways Impact Vascular and Overall Health
As with so many other conditions, in vascular health, patients often need to be seen within a few days or weeks, but current referral systems drag on for many weeks and months.
Why Prevention-Focused Strategies Are Key
Five ways stakeholders can promote screening and treatment for elevated Lp(a) in the future to improve overall cardiac disease mortality
Unlocking Transparency in PBM Pricing
The TSX Venture Exchange has a strong history of helping early-stage health and life sciences companies raise patient capital for research and development.
Merck Drug for Heart and Lung Disorder Wins a First-in-Class FDA Approval
Merck drug Winrevair is the first in a new class of pulmonary arterial hypertension therapies that address a key signaling pathway behind the disease. The drug comes from Merck’s $11.5 billion acquisition of Acceleron Pharma.
Cytokinetics Heart Drug’s Trial Data Look Competitive With BMS Med Camzyos
Cytokinetics drug aficamten met the main goal of a pivotal test in obstructive hypertrophic cardiomyopathy. If approved, the daily pill would compete against a Bristol Myers Squibb drug projected to become a blockbuster seller.
MedArrive, Heartbeat Health Team Up To Offer In-home Cardio Care
In-home provider MedArrive can now connect members of its payer customers, particularly Medicaid plans, to Heartbeat Health for virtual cardiovascular services, the companies announced Tuesday.
Elevance Health: Long Covid Patients Are at Increased Risk for Cardiovascular Problems, Mortality
A recent Elevance Health study found that long Covid patients are 2.35 times more likely to experience cardiac arrhythmia and 3.64 times more likely to experience pulmonary embolism. The study also discovered higher mortality rates among long Covid patients.
The Impact Brands: Empowering Wellness Through Natural and Holistic Solutions
In an era of escalating healthcare costs and a growing preference for natural, holistic approaches to health, The Impact Brands emerges as a collective of diverse brands dedicated to supporting overall wellness through natural means.
CardieX Acquires Blumio, Incorporates Its Wearable Blood Pressure Sensor
CardieX, a cardiovascular technology company based in both Australia and Illinois, recently acquired Blumio, a San Mateo, California-based startup focused on cardiovascular sensors. The deal will advance both companies’ vision to accurately and easily measure blood pressure without relying on the use of a cuff.
Cytokinetics stock soars on heart drug data that sets stage for Phase 3 studies
A Cytokinetics drug in development for treating a rare heart disorder has promising Phase 2 data suggesting it could compete against a Bristol Myers Squibb drug currently under FDA review. Cytokinetics plans to advance its small molecule to Phase 3 testing by the end of this year.
BCBSA to take aim at racial inequities in health, starting with maternal care
The Blue Cross Blue Shield Association recently announced its new national health equity strategy that will focus on maternal health, diabetes, cardiovascular care and mental health. The association's first goal is to cut racial disparities in maternal health by 50% in the next five years.